SYSTEMIC LUPUS
ERYTHEMATOSUS
 Acute or insidious in onset;
 Chronic remitting relapsing illness
characterized by injury to skin,joints,kidney &
serosal membranes
 Most common immunologic disorder to
affect females, age 20-40, [1 in 700; F:M (child
bearing age group) = 9:1; in childhood & old
age 2:1]
Nucleosomal Proteins
& other self antigens
B cell activity
Immune complex and
autoantibody mediated
tissue injury
Clinical manifestations
Drugs (hydralazine,
Procainamide,
D-penicillamine)
UV light
Sex hormones
Family members have
increased risk
Increased incidence in
Identical twins
DQ
C2, C4, C1q Decreased
ANA,
RBC, WBC & platelet
Antibodies
Anti-phospholipid
antibodies
Pathogenesis
RBC, WBC &
platelet Antibodies
Elicit type II
reaction
Large numbers of
circulating immune
complexes make SLE a
prototypical type III
hypersensitivity disease
Types of ANA
• Antibodies to dsDNA.
– Rim or peripheral staining pattern with IF; Highly
specific for SLE; Associated with active renal
disease.
• Antibodies to histones.
– Homogeneous or diffuse staining with IF;
Particularly common in drug induced SLE.
Types of ANA
• Antibodies to non-histones proteins bound to RNA
(Sm antigen, RNP, SS-A, SS-B etc.,).
– Speckled pattern on IF; Sm antigen is specific for SLE; SS-B
is associated with low risk of nephritis; SS-A is seen in
sabacute cutaneous LE; SS-A & SS-B are seen in Sjogren’s.
• Antibodies to nucleolar antigen.
– A few discrete spots on IF; Specific for scleroderma
Highly
Specific
For SLE
Drug induced
SLE
Antinuclear antibodies (ANA)
Thank you

sle.pptx

  • 1.
  • 2.
     Acute orinsidious in onset;  Chronic remitting relapsing illness characterized by injury to skin,joints,kidney & serosal membranes  Most common immunologic disorder to affect females, age 20-40, [1 in 700; F:M (child bearing age group) = 9:1; in childhood & old age 2:1]
  • 3.
    Nucleosomal Proteins & otherself antigens B cell activity Immune complex and autoantibody mediated tissue injury Clinical manifestations Drugs (hydralazine, Procainamide, D-penicillamine) UV light Sex hormones Family members have increased risk Increased incidence in Identical twins DQ C2, C4, C1q Decreased ANA, RBC, WBC & platelet Antibodies Anti-phospholipid antibodies Pathogenesis RBC, WBC & platelet Antibodies Elicit type II reaction Large numbers of circulating immune complexes make SLE a prototypical type III hypersensitivity disease
  • 5.
    Types of ANA •Antibodies to dsDNA. – Rim or peripheral staining pattern with IF; Highly specific for SLE; Associated with active renal disease. • Antibodies to histones. – Homogeneous or diffuse staining with IF; Particularly common in drug induced SLE.
  • 6.
    Types of ANA •Antibodies to non-histones proteins bound to RNA (Sm antigen, RNP, SS-A, SS-B etc.,). – Speckled pattern on IF; Sm antigen is specific for SLE; SS-B is associated with low risk of nephritis; SS-A is seen in sabacute cutaneous LE; SS-A & SS-B are seen in Sjogren’s. • Antibodies to nucleolar antigen. – A few discrete spots on IF; Specific for scleroderma
  • 7.
  • 8.